Streetbeat News

Partnerships

CMND

Clearmind (CMND) has secured exclusive global rights to develop, manufacture, and commercialize innovative compounds invented by Professors Rami Yaka, Ahmed Masaewa, and Avi Priel from The Hebrew University.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:48 am

CMND

Clearmind Medicine has entered into an exclusive patent licensing agreement with Yissum Research Development Company. This agreement grants Clearmind exclusive rights to develop, manufacture, and commercialize novel compounds aimed at treating PTSD and other mental health disorders.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:47 am

BYDDF

BYDDY

NIO

Nio has partnered with BYD, backed by Warren Buffett, to launch a budget-friendly EV brand named 'Onvo', aiming to compete with Tesla's Model Y. This partnership allows Nio to source batteries from BYD, alongside its current supplier CATL, and another provider CALB for different versions of the Onvo EV. This move is part of a broader strategy to reduce costs and compete more effectively in the fiercely competitive Chinese EV market. BYD, having surpassed Tesla in global EV production, is focusing on making EVs more affordable than gasoline vehicles.

Portfolio Pulse from Benzinga Neuro

May 07, 2024 | 11:44 am

AAPL

RIVN

Rivian Automotive, Inc. (NASDAQ:RIVN) saw its stock rise in premarket trading amid rumors of a potential deal with Apple, Inc. (NASDAQ:AAPL). The speculation is based on reports from Digitimes, suggesting Apple is considering a partnership with a U.S. EV startup, likely Rivian. This comes as Rivian prepares to announce its Q1 results, with analysts expecting a loss of $1.17 per share on $1.163 billion in revenue. A deal with Apple could benefit both companies, offering Rivian a lifeline in the competitive EV market and giving Apple exposure to the EV sector.

Portfolio Pulse from Shanthi Rexaline

May 07, 2024 | 11:37 am

LDTC

LeddarTech and Immervision have announced a collaboration to expedite the training of perception models for Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD). This partnership aims to enhance the development and efficiency of ADAS and AD technologies.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:34 am

SPR

Spirit Aerosystems has announced it will not provide guidance until there is further clarity on several key issues, including its acquisition discussions with Boeing, the timing of 737 MAX deliveries and production, and its ongoing commercial negotiations with Airbus.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:34 am

AGEN

LGND

Ligand Pharmaceuticals and Agenus Inc. have entered into a $100M royalty financing agreement to support the clinical development, Phase 3 trial, and launch readiness activities for botensilimab and balstilimab (BOT/BAL). Ligand will receive royalties and milestone payments on six Agenus-partnered programs and on future global net sales of BOT/BAL. The deal also includes an option for up to an additional $125 million in capital through syndication.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:32 am

DIS

PLTR

QQQ

RIVN

SPY

Wall Street shows mixed reactions as earnings from Disney and Palantir disappoint, with futures indicating a varied open. Disney's unexpected pre-market drop, despite profit, and Palantir's negative impact on tech stocks are in focus. Upcoming speeches by Federal Reserve officials and economic reports are also anticipated. SPDR S&P 500 ETF Trust and Invesco QQQ ETF show slight pre-market movements. Analysts remain optimistic about the bull market's return, citing lower interest rates and AI's ongoing relevance. Stocks like Lucid Group and Lumentum Holdings react to earnings announcements, while Rivian gains on Apple partnership rumors.

Portfolio Pulse from Shanthi Rexaline

May 07, 2024 | 11:26 am

GOOG

MSFT

Mustafa Suleyman, co-founder of Google's DeepMind, shared his positive first month experiences at Microsoft, highlighting the company's AI-first approach and supportive culture. His move signifies Microsoft's aggressive push in AI, aiming to outpace competitors like Google. Suleyman's focus on 'Responsible AI' suggests a strategic direction for Microsoft's AI development.

Portfolio Pulse from Benzinga Neuro

May 07, 2024 | 11:11 am

DNA

GreenLab has announced a partnership with Ginkgo Bioworks to increase the production of Brazzein, a new sweetener. This collaboration aims to leverage Ginkgo Bioworks' biotechnology expertise to scale up the manufacturing process of Brazzein, which is known for its high sweetness level and low-calorie content, making it a promising alternative to traditional sugar and artificial sweeteners.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 11:06 am